A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Inclusion Criteria: * Have given a written, informed consent * Be willing and able to follow all instructions * A negative urine pregnancy test if female of childbearing potential Exclusion Criteria: * Known sensitivities to study medication or its components * Any signs of an active infection * Use of disallowed products during the period indicated prior to the enrollment or during the study * Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a positive pregnancy test * Have a condition or a situation which, in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation